Evidence map›Paper›PMID 25926645›Full record

ArticleJournal of virology2015

New Noncoding Lytic Transcripts Derived from the Epstein-Barr Virus Latency Origin of Replication, oriP, Are Hyperedited, Bind the Paraspeckle Protein, NONO/p54nrb, and Support Viral Lytic Transcription.

Subing Cao, Walter Moss, Tina O'Grady, Monica Concha, Michael J Strong, Xia Wang, Yi Yu, Melody Baddoo, Kun Zhang, Claire Fewell and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. The long non-coding RNAOncotarget · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Subing CaoDepartment of Structural and Cellular Biology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
Walter MossDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.
Tina O'GradyDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
Monica ConchaDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
Michael J StrongDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.ORCID http://orcid.org/0000-0001-9930-3578
Xia WangDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
Yi YuDepartment of Cellular and Molecular Biology Graduate Program, Tulane University, New Orleans, Louisiana, USA.
Melody BaddooDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Kun ZhangDepartment of Computer Science, Xavier University of Louisiana, New Orleans, Louisiana, USA.
Claire FewellDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
Zhen LinDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Yan DongDepartment of Structural and Cellular Biology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Erik K FlemingtonDepartment of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA erik@tulane.edu.
Tulane University · USXavier University of Louisiana · USYale University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Xavier's RCMI Cancer Research ProgramG12MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI D'AMOUR, GENE, WANG, GUANGDI · 2012 to 2018
$15.7M
Mentoring a Cancer Genetics ProgramP20GM103518 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2012 to 2013
$4.3M
Epstein Barr virus antisense transcriptionR01AI106676 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2014 to 2018
$1.9M
Intercellular communication in Epstein Barr virus reactivationR01AI101046 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2012 to 2016
$1.9M
Role of the cellular microRNA, miR-155, in EBV type III latency signalingR01CA138268 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2009 to 2013
$1.5M
Human cytomegalovirus in the promotion of glioblastoma multiforme pathogenesisF30CA177267 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI STRONG, MICHAEL JAMES · 2013 to 2016
$129k
EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell LymphomaF31CA180449 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI O'GRADY, CHRISTINA M · 2013 to 2015
$116k
NCI NIH HHS F30 CA177267NCI NIH HHS F30CA177267NCI NIH HHS F31 CA180449NCI NIH HHS F31CA180449NCI NIH HHS R01 CA138268NCI NIH HHS R01CA138268NIAID NIH HHS R01 AI101046NIAID NIH HHS R01AI101046NIAID NIH HHS R01 AI106676NIAID NIH HHS R01AI106676NIGMS NIH HHS P20 GM103518NIGMS NIH HHS P20GM103518NIGMS NIH HHS U54 GM104940NIMHD NIH HHS G12 MD007595
6 · The paper itself

Abstract

unlabelledWe have previously shown that the Epstein-Barr virus (EBV) likely encodes hundreds of viral long noncoding RNAs (vlncRNAs) that are expressed during reactivation. Here we show that the EBV latency origin of replication (oriP) is transcribed bi-directionally during reactivation and that both leftward (oriPtLs) and rightward (oriPtRs) transcripts are largely localized in the nucleus. While the oriPtLs are most likely noncoding, at least some of the oriPtRs contain the BCRF1/vIL10 open reading frame. Nonetheless, oriPtR transcripts with long 5' untranslated regions may partially serve noncoding functions. Both oriPtL and oriPtR transcripts are expressed with late kinetics, and their expression is inhibited by phosphonoacetic acid. RNA sequencing (RNA-seq) analysis showed that oriPtLs and oriPtRs exhibited extensive "hyperediting" at their Family of Repeat (FR) regions. RNA secondary structure prediction revealed that the FR region of both oriPtLs and oriPtRs may form large evolutionarily conserved and thermodynamically stable hairpins. The double-stranded RNA-binding protein and RNA-editing enzyme ADAR was found to bind to oriPtLs, likely facilitating editing of the FR hairpin. Further, the multifunctional paraspeckle protein, NONO, was found to bind to oriPt transcripts, suggesting that oriPts interact with the paraspeckle-based innate antiviral immune pathway. Knockdown and ectopic expression of oriPtLs showed that it contributes to global viral lytic gene expression and viral DNA replication. Together, these results show that these new vlncRNAs interact with cellular innate immune pathways and that they help facilitate progression of the viral lytic cascade. IMPORTANCE: Recent studies have revealed that the complexity of lytic herpesviral transcriptomes is significantly greater than previously appreciated with hundreds of viral long noncoding RNAs (vlncRNAs) being recently discovered. Work on cellular lncRNAs over the past several years has just begun to give us an initial appreciation for the array of functions they play in complex formation and regulatory processes in the cell. The newly identified herpesvirus lncRNAs are similarly likely to play a variety of different functions, although these functions are likely tailored to specific needs of the viral infection cycles. Here we describe novel transcripts derived from the EBV latency origin of replication. We show that they are hyperedited, that they interact with a relatively newly appreciated antiviral pathway, and that they play a role in facilitating viral lytic gene expression. These investigations are a starting point to unraveling the complex arena of vlncRNA function in herpesvirus lytic replication.

Indexed as

Gene Expression Regulation, ViralTranscription, GeneticVirus ReplicationCell LineDNA-Binding ProteinsHerpesvirus 4, HumanHost-Pathogen InteractionsHumansImmunity, InnateNuclear Matrix-Associated ProteinsOctamer Transcription FactorsProtein BindingReplication OriginRNA-Binding ProteinsRNA, UntranslatedDNA-Binding ProteinsNONO protein, humanNuclear Matrix-Associated ProteinsOctamer Transcription FactorsRNA-Binding ProteinsRNA, Untranslated

Identifiers

PMID25926645
PMCPMC4473578
OpenAlexW2142470682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.